Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Study shows that intravitreal injections may significantly slow the disease once thought untreatable
Dr. Anand-Apte named Chair for Ophthalmology Research
Patients with genetic mutation need more than ocular treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Q&A with Network Chair Daniel F. Martin, MD
Immediate implications for refractive surgery
Identifying correct ablation pattern helps select correct IOL calculator
Severity of diabetic retinopathy is a useful predictor
Study evaluates stiffness distribution using Brillouin microscopy
Radiomics analysis suggests underlying subvisual features may encode information related to tolerance of interval extension in retinal vascular disease
Advertisement
Advertisement